UBIAD1 expression is associated with cardiac hypertrophy in spontaneously hypertensive rats

Yan,Bingju; Wang,Jun

doi:10.3892/mmr.2018.9693

UBIAD1 expression is associated with cardiac hypertrophy in spontaneously hypertensive rats

Authors:
- Bingju Yan
- Jun Wang
View Affiliations

Affiliations: Department of Cardiology, First Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China, Department of General Surgery, First Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China
Published online on: November 26, 2018 https://doi.org/10.3892/mmr.2018.9693
Pages: 651-659

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the potential role of UbiA prenyltransferase domain-containing 1 (UBIAD1) in the pathogenesis of hypertensive cardiac hypertrophy. Spontaneously hypertensive rats (SHRs) and Wistar‑Kyoto (WKY) rats at 8, 16 and 28 weeks of age were used. Blood pressure was measured using a non‑invasive tail cut‑off system. Cardiac functional index was assessed by arterial catheterization. Myocardial structure and cell apoptosis were evaluated by hematoxylin and eosin staining, and terminal deoxynucleotidyl‑transferase‑mediated dUTP nick end labeling assays, respectively. Myocardial expression of UBIAD1, coenzyme Q10 (CoQ10), endothelial nitric oxide synthase (eNOS) and atrial natriuretic peptide were evaluated by immunohistochemistry, western blotting and reverse transcription‑quantitative polymerase chain reaction. Circulating and myocardial expression of nitric oxide (NO) were measured using the Griess method. SHRs exhibited increased blood pressure and cardiomyocyte apoptosis, as well as cardiac hypertrophy, compared with age‑matched WKY rats. Myocardial expression of UBIAD1 was significantly decreased in SHRs in an age‑dependent manner. Similarly, myocardial CoQ10 and eNOS expression were significantly reduced in SHR compared to age‑matched WKY rats, and these expression levels additionally decreased further with aging. Serum and myocardial NO expression was additionally decreased in SHRs. Decreased UBIAD1 expression in SHR hearts was associated with decreased levels of CoQ10, eNOS and NO. Given the well‑established role of UBIAD1 in the regulation of NO signaling, reduced expression of UBIAD1 in SHR hearts potentially contributed to the pathogenesis of hypertensive cardiac hypertrophy. Therefore, UBIAD1 may represent a potential therapeutic target for clinical treatment of hypertensive cardiac hypertrophy.

View Figures

View References

1	McGarvey TW, Nguyen T, Puthiyaveettil R, Tomaszewski JE and Malkowicz SB: TERE1, a novel gene affecting growth regulation in prostate carcinoma. Prostate. 54:144–155. 2003. View Article : Google Scholar : PubMed/NCBI
2	Orr A, Dubé MP, Marcadier J, Jiang H, Federico A, George S, Seamone C, Andrews D, Dubord P, Holland S, et al: Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy. PLoS One. 2:e6852007. View Article : Google Scholar : PubMed/NCBI
3	McGarvey TW, Nguyen T, Tomaszewski JE, Monson FC and Malkowicz SB: Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder. Oncogene. 20:1042–1051. 2001. View Article : Google Scholar : PubMed/NCBI
4	Nickerson ML, Kostiha BN, Brandt W, Fredericks W, Xu KP, Yu FS, Gold B, Chodosh J, Goldberg M, Lu DW, et al: UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One. 5:e107602010. View Article : Google Scholar : PubMed/NCBI
5	Mugoni V, Postel R, Catanzaro V, De Luca E, Turco E, Digilio G, Silengo L, Murphy MP, Medana C, Stainier DY, et al: Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell. 152:504–518. 2013. View Article : Google Scholar : PubMed/NCBI
6	Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, Uchino Y, Okuda N, Shimomura Y, Suhara Y and Okano T: Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature. 468:117–121. 2010. View Article : Google Scholar : PubMed/NCBI
7	Hegarty JM, Yang H and Chi NC: UBIAD1-mediated vitamin K2 synthesis is required for vascular endothelial cell survival and development. Development. 140:1713–1719. 2013. View Article : Google Scholar : PubMed/NCBI
8	Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N and Stefanadis C: The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 10:4–18. 2012. View Article : Google Scholar : PubMed/NCBI
9	Vos M, Esposito G, Edirisinghe JN, Vilain S, Haddad DM, Slabbaert JR, Van Meensel S, Schaap O, De Strooper B, Meganathan R, et al: Vitamin K₂ is a mitochondrial electron carrier that rescues pink1 deficiency. Science. 336:1306–1310. 2012. View Article : Google Scholar : PubMed/NCBI
10	Xia Y, Wei X, Wu S, Wang B, Wang X and Hong L: Down-regulation of TERE1/UBIAD1 activated Ras-MAPK signalling and induced cell proliferation. Cell Biol Int Rep. 17:e000052010. View Article : Google Scholar
11	Zhan CD: The role of nitric oxide in the prevention of myocardial hypertrophic response and its mechanisms. Sheng Li Ke Xue Jin Zhan. 31:322–324. 2000.(In Chinese). PubMed/NCBI
12	Wollert KC and Drexler H: Regulation of cardiac remodeling by nitric oxide: Focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev. 7:317–325. 2002. View Article : Google Scholar : PubMed/NCBI
13	Ozaki M, Kawashima S, Yamashita T, Hirase T, Ohashi Y, Inoue N, Hirata K and Yokoyama M: Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J. 66:851–856. 2002. View Article : Google Scholar : PubMed/NCBI
14	Flaherty MP, Brown M, Grupp IL, Schultz JE, Murphree SS and Jones WK: eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol. 7:165–177. 2007. View Article : Google Scholar : PubMed/NCBI
15	Brede M, Roell W, Ritter O, Wiesmann F, Jahns R, Haase A, Fleischmann BK and Hein L: Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension. 42:1177–1182. 2003. View Article : Google Scholar : PubMed/NCBI
16	Yan B, Sun Y and Wang J: Depletion of ubiA prenyltransferase domain containing 1 expression promotes angiotensin II-induced hypertrophic response in AC16 human myocardial cells via modulating the expression levels of coenzyme Q10 and endothelial nitric oxide synthase. Mol Med Rep. 16:6910–6915. 2017. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Ridnour LA, Sim JE, Hayward MA, Wink DA, Martin SM, Buettner GR and Spitz DR: A spectrophotometric method for the direct detection and quantitation of nitric oxide, nitrite, and nitrate in cell culture media. Anal Biochem. 281:223–229. 2000. View Article : Google Scholar : PubMed/NCBI
19	Nordborg C and Johansson BB: Morphometric study on cerebral vessels in spontaneously hypertensive rats. Stroke. 11:266–270. 1980. View Article : Google Scholar : PubMed/NCBI
20	Diez J, Panizo A, Hernández M, Vega F, Sola I, Fortuño MA and Pardo J: Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension. 30:1029–1034. 1997. View Article : Google Scholar : PubMed/NCBI
21	Förstermann U and Sessa WC: Nitric oxide synthases: Regulation and function. Eur Heart J. 33:829–837, 837a-837d. 2012. View Article : Google Scholar : PubMed/NCBI
22	Nakagawa K, Sawada N, Hirota Y, Uchino Y, Suhara Y, Hasegawa T, Amizuka N, Okamoto T, Tsugawa N, Kamao M, et al: Vitamin K₂ biosynthetic enzyme, UBIAD1 is essential for embryonic development of mice. PLoS One. 9:e1040782014. View Article : Google Scholar : PubMed/NCBI
23	Funahashi N, Hirota Y, Nakagawa K, Sawada N, Watanabe M, Suhara Y and Okano T: YY1 positively regulates human UBIAD1 expression. Biochem Biophys Res Commun. 460:238–244. 2015. View Article : Google Scholar : PubMed/NCBI
24	Beketaev I, Zhang Y, Kim EY, Yu W, Qian L and Wang J: Critical role of YY1 in cardiac morphogenesis. Dev Dyn. 244:669–680. 2015. View Article : Google Scholar : PubMed/NCBI
25	Stauffer BL, Dockstader K, Russell G, Hijmans J, Walker L, Cecil M, Demos-Davies K, Medway A, McKinsey TA and Sucharov CC: Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner. Biochem Biophys Res Commun. 462:131–137. 2015. View Article : Google Scholar : PubMed/NCBI
26	Sucharov CC, Dockstader K and McKinsey TA: YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5. Mol Biol Cell. 19:4141–4153. 2008. View Article : Google Scholar : PubMed/NCBI
27	Sucharov CC, Mariner P, Long C, Bristow M and Leinwand L: Yin Yang 1 is increased in human heart failure and represses the activity of the human alpha-myosin heavy chain promoter. J Biol Chem. 278:31233–31239. 2003. View Article : Google Scholar : PubMed/NCBI
28	Kumar A, Kaur H, Devi P and Mohan V: Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol Ther. 124:259–268. 2009. View Article : Google Scholar : PubMed/NCBI
29	Muraro PA, Vergelli M, Kalbus M, Banks DE, Nagle JW, Tranquill LR, Nepom GT, Biddison WE, McFarland HF and Martin R: Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest. 100:339–349. 1997. View Article : Google Scholar : PubMed/NCBI
30	Ghule AE, Kulkarni CP, Bodhankar SL and Pandit VA: Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats. Curr Ther Res Clin Exp. 70:460–471. 2009. View Article : Google Scholar : PubMed/NCBI
31	Fotino AD, Thompson-Paul AM and Bazzano LA: Effect of coenzyme Q₁₀ supplementation on heart failure: A meta-analysis. Am J Clin Nutr. 97:268–275. 2013. View Article : Google Scholar : PubMed/NCBI
32	Sharma A, Fonarow GC, Butler J, Ezekowitz JA and Felker GM: Coenzyme Q10 and heart failure: A state-of-the-art review. Circ Heart Fail. 9:e0026392016. View Article : Google Scholar : PubMed/NCBI
33	Chew GT and Watts GF: Coenzyme Q10 and diabetic endotheliopathy: Oxidative stress and the ‘recoupling hypothesis’. QJM. 97:537–548. 2004. View Article : Google Scholar : PubMed/NCBI
34	Tsai KL, Huang YH, Kao CL, Yang DM, Lee HC, Chou HY, Chen YC, Chiou GY, Chen LH, Yang YP, et al: A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem. 23:458–468. 2012. View Article : Google Scholar : PubMed/NCBI
35	Forstermann U and Münzel T: Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation. 113:1708–1714. 2006. View Article : Google Scholar : PubMed/NCBI
36	Bian K, Doursout MF and Murad F: Vascular system: Role of nitric oxide in cardiovascular diseases. J Clin Hypertens. 10:304–310. 2008. View Article : Google Scholar
37	Kang JH, Wiggs JL, Rosner BA, Haines J, Abdrabou W and Pasquale LR: Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: Interactions with hypertension, alcohol intake and cigarette smoking. Arch Ophthalmol. 129:773–780. 2011. View Article : Google Scholar : PubMed/NCBI
38	Li Q, Youn JY and Cai H: Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens. 33:1128–1136. 2015. View Article : Google Scholar : PubMed/NCBI
39	Wang X, Wang D, Jing P, Wu Y, Xia Y, Chen M and Hong L: A novel Golgi retention signal RPWS for tumor suppressor UBIAD1. PLoS One. 8:e720152013. View Article : Google Scholar : PubMed/NCBI
40	Fredericks WJ, McGarvey T, Wang H, Lal P, Puthiyaveettil R, Tomaszewski J, Sepulveda J, Labelle E, Weiss JS, Nickerson ML, et al: The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: Implications for tumor progression. DNA Cell Biol. 30:851–864. 2011. View Article : Google Scholar : PubMed/NCBI